Mode
Text Size
Log in / Sign up

Antisynthetase syndrome can mimic cellulitis, with skin, muscle, and lung improvement on immunosuppressionDoctors Report Rare Muscle Disease That Looked Like Cellulitis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider antisynthetase syndrome when cellulitis-like edema accompanies elevated muscle enzymes and ILD.

This is a case report with a targeted literature review, not a controlled trial. It describes a 72-year-old woman who presented with unilateral lower limb cellulitis-like edema and was ultimately diagnosed with antisynthetase syndrome, an idiopathic inflammatory myopathy that can involve the skin, muscles, and lungs.

The patient was treated with prednisone, mycophenolate mofetil, and nintedanib. Over a 3-month follow-up, the authors report that skin lesions completely resolved, muscle enzymes (creatine kinase and lactate dehydrogenase) nearly normalized, interstitial lung disease improved, and pleural and pericardial effusions markedly decreased. No effect sizes, absolute numbers, p-values, or confidence intervals were reported for any outcome.

Safety data are limited. Adverse events and serious adverse events were not reported. Cefuroxime sodium was discontinued after 5 days, but the reason for discontinuation is not specified. Tolerability was not reported.

The authors acknowledge that this is a single case report, and the atypical cutaneous manifestation limits generalizability. The findings cannot establish that the observed improvements were caused by the treatment regimen rather than the natural history of the disease or other factors.

The clinical relevance is primarily diagnostic: antisynthetase syndrome may mimic infectious cellulitis, and inflammatory myopathy should be considered when atypical skin lesions are accompanied by elevated muscle enzymes and interstitial lung disease. This is a reminder to maintain a broad differential, not evidence for a specific treatment approach.

How this fits prior evidence

This case report extends prior coverage of interstitial lung disease and autoimmune overlap by describing antisynthetase syndrome presenting as cellulitis-like edema, a cutaneous mimic that could delay diagnosis. It aligns with prior observations that autoantibody positivity and negative cytology can mask invasive mucinous adenocarcinoma in patients with IPAF, reinforcing that autoimmune features can obscure other diagnoses. It also echoes the principle that skin lesions may precede other manifestations, as seen in follicular occlusion triad and spondyloarthritis. Unlike the randomized evidence for inhaled treprostinil in pulmonary hypertension associated with ILD, this report provides no comparative efficacy data and cannot inform treatment selection.

A swollen, red leg usually means cellulitis, a common skin infection. But for one 72-year-old woman, that wasn't the whole story. Doctors describe her case in a new report: what looked like cellulitis turned out to be antisynthetase syndrome, a rare autoimmune condition that attacks muscles and lungs. The report is a single case, so it is a clue, not proof.

The woman had a swollen lower leg that looked infected. But she also had skin lesions, rising muscle enzymes, and lung problems. Those clues pointed away from infection and toward an inflammatory myopathy, a disease where the immune system attacks muscle. Doctors treated her with prednisone, mycophenolate mofetil, and nintedanib. After three months, her skin lesions cleared, her muscle enzymes nearly normalized, and her lung disease improved. Her pleural and pericardial effusions, extra fluid around the lungs and heart, decreased markedly.

She stopped one antibiotic, cefuroxime sodium, after five days. No other side effects were reported. But this is one person's experience. A case report cannot show that a treatment works for everyone, or even that it caused the improvement. It simply raises a flag: when atypical skin lesions come with high muscle enzymes and lung disease, doctors should think beyond infection. That is the real message here.

What this means for you:
A rare muscle disease can look like a common skin infection. Unusual skin signs plus muscle and lung problems are a clue.

Common questions

What is antisynthetase syndrome?

It is a rare autoimmune disease that causes muscle weakness and lung problems. In this case, it also caused skin lesions that looked like an infection. Doctors consider it when someone has atypical skin findings along with high muscle enzymes and interstitial lung disease. It is not an infection, so antibiotics alone will not fix it.

How was this case treated?

The 72-year-old woman received prednisone, mycophenolate mofetil, and nintedanib. After three months, her skin lesions resolved, her muscle enzymes nearly normalized, and her lung disease improved. She also received cefuroxime sodium for five days, which was then stopped. This is one person's treatment, not a standard plan for everyone.

Was the treatment safe?

The report does not list any side effects from the main treatments. The only noted discontinuation was cefuroxime sodium, stopped after five days. Because this is a single case, safety information is very limited. Always talk with your doctor about the risks and benefits of any treatment for your situation.

What should I do if I have similar symptoms?

If you have unusual skin lesions along with muscle weakness or breathing problems, see your doctor. This case shows that a rare muscle disease can mimic a common infection. Only a doctor can tell the difference and decide what tests or treatments you need. Do not try to diagnose or treat yourself.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
BackgroundAntisynthetase syndrome (ASyS) is a distinct subtype of idiopathic inflammatory myopathy (IIM), characterized by multisystem involvement, including the lungs, skin, skeletal muscles, and joints, as well as the presence of anti-aminoacyl-tRNA synthetase (ARS) antibodies. While 8% to 30% of patients present with classic dermatomyositis-like rashes, atypical skin involvement can also occur. Rarely, patients may develop cutaneous edema that mimics cellulitis, which is highly susceptible to misdiagnosis.Case presentationA 72-year-old woman presented with a 1-week history of erythema, swelling, and pain in the right lower limb. Physical examination showed marked edema with a peau d’orange appearance, local warmth, and tenderness. Given the detection of fungal hyphae on the right foot, cellulitis was initially suspected. However, the lesions did not improve after 5 days of cefuroxime sodium treatment, and she developed right gastrocnemius tenderness, markedly elevated muscle enzymes, and interstitial changes on chest computed tomography. Myositis antibody testing was positive for anti-melanoma differentiation-associated gene 5(anti-MDA5) and anti-histidyl-tRNA synthetase(anti-Jo-1) antibodies. Right gastrocnemius biopsy showed fiber-size variation and scattered endomysial inflammatory infiltration, without necrosis or perifascicular atrophy; immunohistochemistry showed focal/patchy major histocompatibility complex class I (MHC-I) expression and weak non-perifascicular sarcoplasmic myxovirus resistance protein A (MxA) positivity. Antisynthetase syndrome was diagnosed. Moderate-dose oral prednisone was added and cefuroxime sodium was discontinued. Eight days later, erythema, swelling, and myalgia improved, with marked decreases in muscle enzymes and hypersensitive C-reactive protein(hs-CRP). After discharge, mycophenolate mofetil(MMF) and nintedanib were added. Three months later, the skin lesions had completely resolved, creatine kinase, lactate dehydrogenase, high-sensitivity troponin, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) nearly normalized; interstitial lung disease (ILD) improved, and pleural/pericardial effusions markedly decreased.DiscussionNotably, this case highlights that ASyS may mimic infectious cellulitis and cause misdiagnosis. Inflammatory myopathy should be considered when atypical skin lesions are accompanied by elevated muscle enzymes and ILD.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.